Iovance Biotherapeutics (IOVA) Depreciation and Depletion (2020 - 2023)
Iovance Biotherapeutics (IOVA) posted quarterly Depreciation and Depletion of $2.9 million for Q2 2023, up 31.82% year-over-year from $2.2 million in Q2 2022, and up 3.57% quarter-over-quarter from $2.8 million in Q1 2023.
Iovance Biotherapeutics (IOVA) Depreciation and Depletion (2020 - 2023) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Depreciation and Depletion for 4 consecutive years, with $2.9 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Depreciation and Depletion rose 31.82% year-over-year to $2.9 million; the TTM figure through Jun 2023 stood at $11.0 million (up 74.6% YoY), while the FY2022 annual figure was $9.3 million, up 200.0% from the prior year.
- Depreciation and Depletion improved to $2.9 million in Q2 2023 per IOVA's latest filing, from $2.8 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2.9 million in Q2 2023 and bottomed at $200000.0 in Q2 2020.
- Historically, Depreciation and Depletion has averaged $1.4 million across 4 years, with a median of $1.2 million in 2021.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion jumped 633.33% — and 2023, when it surged 31.82%.
- Iovance Biotherapeutics' Depreciation and Depletion stood at $300000.0 in 2020, then jumped by 333.33% to $1.3 million in 2021, then soared by 115.38% to $2.8 million in 2022, then grew by 3.57% to $2.9 million in 2023.
- Business Quant data shows IOVA's Depreciation and Depletion at $2.9 million in Q2 2023, $2.8 million in Q1 2023, and $2.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 2.80 Mn |
| Mar 31, 2023 | 2.80 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 400,000.00 |
| Mar 31, 2021 | 400,000.00 |